| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.058 | 42.848 | 63.657 | 83.611 | 86.915 | 168.798 | 182.905 | 266.387 | 319.956 |
| Total Income - EUR | - | 2.058 | 42.848 | 63.657 | 83.611 | 86.921 | 168.798 | 183.106 | 266.387 | 319.956 |
| Total Expenses - EUR | - | 788 | 31.584 | 62.172 | 65.747 | 63.632 | 113.461 | 146.303 | 198.075 | 245.841 |
| Gross Profit/Loss - EUR | - | 1.269 | 11.264 | 1.485 | 17.863 | 23.289 | 55.337 | 36.802 | 68.312 | 74.115 |
| Net Profit/Loss - EUR | - | 1.208 | 10.836 | 848 | 17.028 | 22.419 | 53.649 | 35.246 | 66.048 | 65.956 |
| Employees | - | 1 | 2 | 4 | 7 | 6 | 7 | 8 | 8 | 8 |
Check the financial reports for the company - Translar Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 116 | 8.759 | 14.191 | 23.818 | 26.283 | 51.289 | 57.986 | 74.117 | 65.783 |
| Current Assets | - | 2.528 | 5.699 | 6.520 | 13.034 | 32.769 | 32.226 | 31.231 | 78.351 | 151.700 |
| Inventories | - | 917 | 2.060 | 5.870 | 5.967 | 7.219 | 11.714 | 14.149 | 21.024 | 24.736 |
| Receivables | - | 0 | 0 | 0 | 122 | 244 | 1.239 | 237 | 1.348 | 2.806 |
| Cash | - | 1.612 | 3.639 | 649 | 6.944 | 25.306 | 19.274 | 16.845 | 55.979 | 124.158 |
| Shareholders Funds | - | 1.252 | 12.067 | 12.693 | 29.475 | 51.336 | 69.764 | 75.418 | 141.238 | 206.405 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.392 | 2.391 | 8.017 | 7.376 | 7.716 | 13.751 | 13.798 | 11.231 | 25.798 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Translar Med S.r.l.